AGP Picks
View all

Reporting on science and technology news in New Jersey

Provided by AGP

Technology Times New Jersey: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Times New Jersey.

Press releases published on March 26, 2026

NeuroKaire Cleared in 49 of 50 States, So Physicians Can See Which Antidepressants Best Fit Each Patient's Biology
Vemanti Group Issues Statement Regarding Ongoing Investigation Related to ONUS Pro Platform
Rising Tide Capital Appoints Dr. Joynicole Martinez as Chief Executive Officer & President
DPC DATA Launches AI-Ready Municipal Bond Data for Institutional Investors
Silo Introduces Silo v3, a New Class of Money Markets Designed to Remain Solvent Without Reliance on DEX Liquidity
XORTX Announces Results of  Annual and Special Meeting of Shareholders
Datacentrex Announces Pricing of $20.17 Million Confidentially Marketed Public Offering at $2.00 per Share
Agicap Selects Chargebee to Power Its Next Phase of Global Growth
DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document
DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistrement Universel 2025
Rumble Announces Chief Financial Officer Transition
LeonaBio Reports Full Year 2025 Financial Results and Provides Business Update
ZenaTech presentará sus últimos desarrollos en drones interceptores, sistema de defensa contra UAS, ZenaDrone y Zena AI en próximas conferencias de inversionistas y eventos del sector
DBV Technologies publie ses résultats financiers annuels 2025 et fait le point sur ses activités
DBV Technologies Reports Full Year 2025 Financial Results and Business Update
Vaidio’s Vision AI Platform Wins SIA 2026 Award for Design, Diagnostic, and Installation Tools
Calian Increases its Committed Credit Facility to Pursue Growth and Announces Management Change
XORTX Announces Change of Effective Date of Share Consolidation
Onco360® Has Been Selected as the National Pharmacy Partner for LIFYORLI™ (relacorilant)
Disc Medicine Announces Completion of Enrollment of Phase 3 APOLLO Trial of Bitopertin in Erythropoietic Protoporphyria

Share us

on your social networks:

Sign up for:

Technology Times New Jersey

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.